Krisztian Homicsko

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

Cancers

Cancer biology & therapy

International journal of molecular sciences

Science immunology

Centre Hospitalier Universitaire Vaudois Département d'oncologie CHUV-UNIL

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centre Hospitalier Universitaire Vaudois Département d'oncologie CHUV-UNIL Jan 01 2011

Switzerland

Attending Physician/Chef de clinique :: Oncology

Centre Hospitalier Universitaire Vaudois Département d'oncologie CHUV-UNIL Mar 01 2009 - Jan 01 2011

Switzerland

Trainee in medical oncology :: Oncology

Institute Curie Jan 11 2007 - Mar 01 2009

France

Medicine assistant :: Hopital, Oncologie

Tayside NHS Board Jan 01 2007 - Jan 07 2007

United Kingdom

Senior House officer :: Oncology

University of St Andrews Jan 11 2005 - Jan 01 2007

United Kingdom

Post-doc :: Medical School

Publications

David König, Michael T Sandholzer, Sarp Uzun, Andreas Zingg, Reto Ritschard, Helen Thut, Katharina Glatz, Elisabeth Artemis Kappos, Dirk J Schaefer, Christoph Kettelhack, Jakob R Passweg, Andreas Holbro, Katharina Baur, Michael Medinger, Andreas S Buser, Didier Lardinois, Lukas T Jeker, Nina Khanna, Frank Stenner, Benjamin Kasenda, Krisztian Homicsko, Matthias S Matter, Natalia Rodrigues Mantuano, Alfred Zippelius, Heinz Laubli
Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes. Cancer immunology research 12 (7) (2024)
David Barras, Eleonora Ghisoni, Johanna Chiffelle, Angela Orcurto, Julien Dagher, Noémie Fahr, Fabrizio Benedetti, Isaac Crespo, Alizée J Grimm, Matteo Morotti, Stefan Zimmermann, Rafael Duran, Martina Imbimbo, Maria Ochoa de Olza, Blanca Navarro, Krisztian Homicsko, Sara Bobisse, Danny Labes, Zoe Tsourti, Charitini Andriakopoulou, Fernanda Herrera, Rémy Pétremand, Reinhard Dummer, Gregoire Berthod, Anne I Kraemer, Florian Huber, Jonathan Thevenet, Michal Bassani-Sternberg, Niklaus Schaefer, John O Prior, Maurice Matter, Aedo Lopez Veronica, Clarisse Dromain, Jesus Corria-Osorio, Stéphanie R Tissot, Lana Elias Kandalaft, Raphaël Gottardo, Mikaël J Pittet, Christine Sempoux, Olivier Michielin, Urania Dafni, Lionel Trueb, Alexandre Harari, Denarda Dangaj Laniti, Sergio A Quezada
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 + T-myeloid cell networks in melanoma. Science immunology 9 (92) (2024)
David Barras, Eleonora Ghisoni, Johanna Chiffelle, Angela Orcurto, Julien Dagher, Noémie Fahr, Fabrizio Benedetti, Isaac Crespo, Alizée J Grimm, Matteo Morotti, Stefan Zimmermann, Rafael Duran, Martina Imbimbo, Maria Ochoa de Olza, Blanca Navarro, Krisztian Homicsko, Sara Bobisse, Danny Labes, Zoe Tsourti, Charitini Andriakopoulou, Fernanda Herrera, Rémy Pétremand, Reinhard Dummer, Gregoire Berthod, Anne I Kraemer, Florian Huber, Jonathan Thevenet, Michal Bassani-Sternberg, Niklaus Schaefer, John O Prior, Maurice Matter, Aedo Lopez Veronica, Clarisse Dromain, Jesus Corria-Osorio, Stéphanie R Tissot, Lana Elias Kandalaft, Raphaël Gottardo, Mikaël J Pittet, Christine Sempoux, Olivier Michielin, Urania Dafni, Lionel Trueb, Alexandre Harari, Denarda Dangaj Laniti, Sergio A Quezada
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 + T-myeloid cell networks in melanoma. Science immunology 9 (92) (2024)
David Barras, Eleonora Ghisoni, Johanna Chiffelle, Angela Orcurto, Julien Dagher, Noémie Fahr, Fabrizio Benedetti, Isaac Crespo, Alizée J Grimm, Matteo Morotti, Stefan Zimmermann, Rafael Duran, Martina Imbimbo, Maria Ochoa de Olza, Blanca Navarro, Krisztian Homicsko, Sara Bobisse, Danny Labes, Zoe Tsourti, Charitini Andriakopoulou, Fernanda Herrera, Rémy Pétremand, Reinhard Dummer, Gregoire Berthod, Anne I Kraemer, Florian Huber, Jonathan Thevenet, Michal Bassani-Sternberg, Niklaus Schaefer, John O Prior, Maurice Matter, Aedo Lopez Veronica, Clarisse Dromain, Jesus Corria-Osorio, Stéphanie R Tissot, Lana Elias Kandalaft, Raphaël Gottardo, Mikaël J Pittet, Christine Sempoux, Olivier Michielin, Urania Dafni, Lionel Trueb, Alexandre Harari, Denarda Dangaj Laniti, Sergio A Quezada
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 + T-myeloid cell networks in melanoma. Science immunology 9 (92) (2024)
David König, Michael T Sandholzer, Sarp Uzun, Andreas Zingg, Reto Ritschard, Helen Thut, Katharina Glatz, Elisabeth Artemis Kappos, Dirk J Schaefer, Christoph Kettelhack, Jakob R Passweg, Andreas Holbro, Katharina Baur, Michael Medinger, Andreas S Buser, Didier Lardinois, Lukas T Jeker, Nina Khanna, Frank Stenner, Benjamin Kasenda, Krisztian Homicsko, Matthias S Matter, Natalia Rodrigues Mantuano, Alfred Zippelius, Heinz Laubli
Melanoma clonal heterogeneity leads to secondary resistance after adoptive cell therapy with tumor-infiltrating lymphocytes. Cancer immunology research (2024)
Sandro Anchisi, Anita Wolfer, Bettina Bisig, Edoardo Missiglia, Amine Tiab, Ehab Mohamed Kamel, Olivier Michielin, George Coukos, Krisztian Homicsko
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient. Cancer biology & therapy 24 (1) (2023)
Sandro Anchisi, Anita Wolfer, Bettina Bisig, Edoardo Missiglia, Amine Tiab, Ehab Mohamed Kamel, Olivier Michielin, George Coukos, Krisztian Homicsko
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient. Cancer biology & therapy 24 (1) (2023)
Fanny Seraphine Krebs, Bianca Moura, Edoardo Missiaglia, Veronica Aedo-Lopez, Olivier Michielin, Petros K Tsantoulis, Bettina Bisig, Mounir Trimech, Vincent Zoete, Krisztian Homicsko
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma. International journal of molecular sciences 24 (5) (2023)
Krisztian Homicsko, Panagiota Zygoura, Maxim Norkin, Stephanie Tissot, Nicholas Shakarishvili, Sanjay Popat, Alessandra Curioni-Fontecedro, Mary O'Brien, Anthony Pope, Riyaz Shah, Patricia Fisher, James F Spicer, Amy Roy, David Gilligan, Sylvie Rusakiewicz, Ekaterina Fortis, Nesa Marti, Roswitha Kammler, Stephen P Finn, Georges Coukos, Urania Dafni, Solange Peters, Rolf A Stahel
PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma. Journal for immunotherapy of cancer 11 (10) (2023)
Fanny Seraphine Krebs, Bianca Moura, Edoardo Missiaglia, Veronica Aedo-Lopez, Olivier Michielin, Petros K Tsantoulis, Bettina Bisig, Mounir Trimech, Vincent Zoete, Krisztian Homicsko
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma. International journal of molecular sciences 24 (5) (2023)
Fanny Seraphine Krebs, Bianca Moura, Edoardo Missiaglia, Veronica Aedo-Lopez, Olivier Michielin, Petros K Tsantoulis, Bettina Bisig, Mounir Trimech, Vincent Zoete, Krisztian Homicsko
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma. International journal of molecular sciences 24 (5) (2023)
Sandro Anchisi, Anita Wolfer, Bettina Bisig, Edoardo Missiglia, Amine Tiab, Ehab Mohamed Kamel, Olivier Michielin, George Coukos, Krisztian Homicsko
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient. Cancer biology & therapy 24 (1) (2023)
Qiqun Zeng, Sadegh Saghafinia, Agnieszka Chryplewicz, Nadine Zangger, Lucine Christe, Yu-Qing Xie, Jeremy Guillot, Simge Yucel, Pumin Li, José A Galván, Eva Karamitopoulou, Inti Zlobec, Dalya Ataca, Fleuriane Gallean, Peng Zhang, José Antonio Rodriguez-Calero, Mark Rubin, Melanie Tichet, Krisztian Homicsko, Douglas Hanahan
Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion. Science (New York, N.Y.) 378 (6621) (2022)
Bianca Gautron Moura, Camille L Gerard, Nathalie Testart, Marian Caikovski, Alexandre Wicky, Veronica Aedo-Lopez, Grégoire Berthod, Krisztian Homicsko, John O Prior, Clarisse Dromain, Lana Elias Kandalaft, Michel A Cuendet, Olivier Michielin
Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma. Cancers 15 (1) (2022)
Veronica Aedo-Lopez, Camille L Gerard, Sarah Boughdad, Bianca Gautron Moura, Gregoire Berthod, Antonia Digklia, Krisztian Homicsko, Niklaus Schaefer, Rafael Duran, Michel A Cuendet, Olivier Michielin
Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma. Cancers 14 (5) (2022)
Bianca Gautron Moura, Camille L Gerard, Nathalie Testart, Marian Caikovski, Alexandre Wicky, Veronica Aedo-Lopez, Grégoire Berthod, Krisztian Homicsko, John O Prior, Clarisse Dromain, Lana Elias Kandalaft, Michel A Cuendet, Olivier Michielin
Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma. Cancers 15 (1) (2022)
Krisztian Homicsko, Reinhard Dummer, Christoph Hoeller, Jedd D Wolchok, F Stephen Hodi, James Larkin, Paolo Antonio Ascierto, Victoria Atkinson, Caroline Robert, Michael A Postow, Sandra Re, David Paulucci, Darin Dobler, Olivier Michielin
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma. Cancers 14 (9) (2022)
Bianca Gautron Moura, Camille L Gerard, Nathalie Testart, Marian Caikovski, Alexandre Wicky, Veronica Aedo-Lopez, Grégoire Berthod, Krisztian Homicsko, John O Prior, Clarisse Dromain, Lana Elias Kandalaft, Michel A Cuendet, Olivier Michielin
Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma. Cancers 15 (1) (2022)
Daniele Frisone, Melinda Charrier, Sophie Clement, Yann Christinat, Laure Thouvenin, Krisztian Homicsko, Olivier Michielin, Alexandre Bodmer, Pierre O Chappuis, Thomas A McKee, Petros K Tsantoulis
Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss. Cancer biology & therapy 21 (3) (2019)

Krisztian Homicsko.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Krisztian Homicsko